Both in Pharmaceuticals
Rallybio vs Polaryx Therapeutics
Over the past year RLYB returned +196.1% and PLYX returned −95.0%; their daily moves had a correlation of -0.04.
RLYB +196.1% PLYX −95.0%Growth of $1, one year, split-adjusted
| Metric | RLYB | PLYX |
|---|---|---|
| Price | $15.54 | $1.75 |
| Market cap | $83.7M | $87.2M |
| Today | +0.84% | −5.91% |
| 1 month | −7.3% | −13.4% |
| 6 months | +65.1% | −64.1% |
| Year to date | +183.1% | — |
| 1 year | +220.9% | — |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | 3.1× | — |
| Price / sales | 192.8× | — |
| Net cash | $90.7M | $11.5M |
| Dividend yield | — | — |
| Volatility (60d) | 24.4% | 69.2% |
| Short % of float | 1.6% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).